EUVIMEDEUVIMED entdecken
Crossref

De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes

Yan Zhu, Jiaolong Meng, Bo Feng, Yao Zhao, Yi Zang, Lingling Lu, Mingbo Su, Qi Yang, Qi Zhang, Lu Feng, Jinyi Zhao, Maolin Shao und 6 weitere

Structure · 2024

DOI: 10.1016/j.str.2024.05.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2024. Verfasst von Yan Zhu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Na…. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Drug Design, Protease Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Coronavirus 3C ProteasesDrug DesignProtease InhibitorsAntiviral AgentsProtein BindingHumansBinding SitesCatalytic DomainModels, MolecularCrystallography, X-RayMolecular Docking SimulationCOVID-19 Drug Treatment

Stichwörter der Autor:innen

SARS-CoV-2coronavirusdrug resistanceinhibitormain protease

Substanzen

Coronavirus 3C ProteasesProtease InhibitorsAntiviral Agents3C-like proteinase, SARS-CoV-2

Autor:innen und Institutionen

  • Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; National Clinical Research Center for Infectious Disease, Shenzhen Third…
  • State Key Laboratory of Molecular & Process Engineering, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.
  • The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, China. Electronic address: zhaoyao@shanghaitech.edu.cn.
  • The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Lingang Laboratory, Shanghai 200031, China.
  • Guangzhou National Laboratory, Guangzhou, Guangdong 510005, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Y., Meng, J., Feng, B., Zhao, Y., Zang, Y., Lu, L., Su, M., Yang, Q., Zhang, Q., Feng, L., Zhao, J., Shao, M., Ma, Y., Yang, X., Yang, H., Li, J., Jiang, X., & Rao, Z. (2024). De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes. Structure. https://doi.org/10.1016/j.str.2024.05.019

Vancouver

Zhu Y, Meng J, Feng B, Zhao Y, Zang Y, Lu L, et al. De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes. Structure. 2024. doi:10.1016/j.str.2024.05.019

BibTeX
@article{Zhu2024,
  author = {Zhu, Yan and Meng, Jiaolong and Feng, Bo and Zhao, Yao and Zang, Yi and Lu, Lingling and Su, Mingbo and Yang, Qi and Zhang, Qi and Feng, Lu and Zhao, Jinyi and Shao, Maolin and Ma, Yuanyuan and Yang, Xiuna and Yang, Haitao and Li, Jia and Jiang, Xuefeng and Rao, Zihe},
  title = {De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes},
  journal = {Structure},
  year = {2024},
  doi = {10.1016/j.str.2024.05.019}
}
Kostenlos starten →